QUOTE AND NEWS
StreetInsider.com  Nov 5  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Genoptix+%28GXDX%29+Rops+Q3+EPS+by+21c%3B+Guides+Higher+for+FY09%3B+2010+Revs+In-line/5081241.html for the full story.
PR Newswire  Nov 5  Comment 
CARLSBAD, Calif., Nov. 5 /PRNewswire-FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX), a specialized laboratory services provider, today reported revenues of $50.8 million for the third quarter of 2009, which includes a $4.4 million benefit from changes
PR Newswire  Oct 22  Comment 
CARLSBAD, Calif., Oct. 22 /PRNewswire-FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX), a provider of personalized diagnostic services, announced today that it expects to report its financial results for the third quarter of 2009 after closing of the
PR Newswire  Oct 20  Comment 
CARLSBAD, Calif., Oct. 20 /PRNewswire-FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX), a specialized laboratory services provider, today announced that it ranked number 15 on Technology Fast 500(TM), Deloitte LLP's ranking of 500 of the fastest growing
Motley Fool  Sep 21  Comment 
The insider sell/buy ratio hit an all-time high. Something is bothering insiders.
newratings.com  Sep 4  Comment 
NEW YORK, September 4 (newratings.com) - Analysts at Global Hunter Securities reinitiate coverage of Genoptix Inc (ticker: GXDX) with a "buy" rating. The target price is set to $41. [more]
newratings.com  Sep 4  Comment 
PR Newswire  Aug 13  Comment 
CARLSBAD, Calif., Aug. 13 /PRNewswire-FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX), a specialized laboratory services provider, today announced the Company's participation at the 2009 Southern California Investor Conference scheduled to take place at
Motley Fool  Aug 5  Comment 
Like the smart hedge fund operators, these CAPS investors bet against a stock -- and won big!
Motley Fool  Jul 31  Comment 
Maybe what glitters really is gold.
StreetInsider.com  Jul 30  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Guidance/Genoptix+%28GXDX%29+Tops+Q2+EPS+by+13c%3B+Guides+Higher+for+FY/4832753.html for the full story.
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 
 
TOP CONTRIBUTORS
GXDX AT A GLANCE
 
 
 
 
 
 
 
 

Genoptix, Inc. (GXDX) is a relatively small player in the laboratory diagnostic field, and yet it is one of the most well respected companies within its field. The firm focuses exclusively on serving Hematologists and Oncologists in diagnosing their patient’s illnesses. Most of the diagnostic tests are run on bone marrow samples which are very difficult and painful to extract from the patients. Because doctors consider these samples so precious, and the prospect of potentially drawing another sample is so unattractive, doctors typically are receptive to sending samples to this smaller more specialized lab rather than sending the bone marrow to a competitor.

While Quest Diagnostics Incorporated (DGX), and Genzyme Corporation (GENZ) may be able to perform the same tests, Genoptix is able to win some business from these firms because of their special focus, their customer service, and the willingness of lab physicians to consult with the doctor to adequately diagnose the patients condition.

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki